Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2026-03-03 @ 11:27 AM
Study NCT ID:
NCT00543218
Status:
COMPLETED
Last Update Posted:
2007-10-12
First Post:
2007-10-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PTH Comparison in Post Menopausal Women
Sponsor:
Eli Lilly and Company
Organization:
Study Overview
Official Title:
Comparison of Teriparatide and Calcitonin in the Treatment of Postmenopausal Women With Osteoporosis
Status:
COMPLETED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Compare in postmenopausal women with established osteoporosis the effect of treatment with teriparatide 20 micrograms/day subcutaneous with the effect of salmon calcitonin 100 IU/day subcutaneous on change in lumbar spine BMD.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| B3D-TW-GHCB | None | None | View |